Skip to content

Investing
Personal Finance
Technology
Economy and Geopolitics
Trending Articles

20 minutes ago

Are Travel Points Credit Cards a Smart Strategy or a Deception?

33 minutes ago

Joint Bank Accounts Are Dying: Why Just 77% of Married Couples Share Money Now
AI Portfolio

AI Investor Podcast

Investing
Personal Finance
Technology
Economy and Geopolitics
- Economy
- Politics
- Crime
- Infrastructure
- Military
AI Portfolio

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Sarepta Scores Big on Highly Contested FDA Approval

Chris Lange | Sep 19, 2016 at 12:25 PM EDT

Sarepta Scores Big on Highly Contested FDA Approval

Sarepta Therapeutics cleared another hurdle related to its Duchenne muscular dystrophy treatment, and the stock practically doubled on Monday.

Community Health May Be Planning Sale

Chris Lange | Sep 19, 2016 at 10:20 AM EDT

Community Health May Be Planning Sale

Shares of Community Health Systems retreated on Monday, after making a sizable gain in Friday’s session on news that the…

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Lee Jackson | Sep 19, 2016 at 8:25 AM EDT

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

Is This the Ultimate Implosion of Novavax?

Chris Lange | Sep 16, 2016 at 10:35 AM EDT

Is This the Ultimate Implosion of Novavax?

Novavax was pummeled by shareholders on Friday after the company reported top-line results from its RSV F Vaccine trials.

Has AcelRx Pharmaceuticals Hit a Home Run?

Chris Lange | Sep 16, 2016 at 7:20 AM EDT

Has AcelRx Pharmaceuticals Hit a Home Run?

Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an…

Caladrius Bio Jumps on Private Placement Deal

Chris Lange | Sep 15, 2016 at 12:35 PM EDT

Caladrius Bio Jumps on Private Placement Deal

Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.

Why Aeri Pharma Won So Big on a Single Trial

Chris Lange | Sep 15, 2016 at 8:40 AM EDT

Why Aeri Pharma Won So Big on a Single Trial

Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in…

Why This FDA Departure Is Huge for Sarepta

Chris Lange | Sep 14, 2016 at 4:37 PM EDT

Why This FDA Departure Is Huge for Sarepta

Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne…

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars

Jon C. Ogg | Sep 14, 2016 at 3:02 PM EDT

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars

It is not that often that you see biotech or biohealth stocks moving north of 50% in one trading session.…

Agios Files for Secondary Offering

Chris Lange | Sep 14, 2016 at 10:35 AM EDT

Agios Files for Secondary Offering

Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.

Vitae Shares Jump Over 150% on Allergan Acquisition

Chris Lange | Sep 14, 2016 at 10:25 AM EDT

Vitae Shares Jump Over 150% on Allergan Acquisition

The goal of Allergan’s bid for Vitae Pharmaceuticals is to bolster its dermatology product pipeline, and Vitae shareholders appear happy…

Key FDA Decisions and Trial Results Coming in the Next 2 Months

Chris Lange | Sep 14, 2016 at 8:20 AM EDT

Key FDA Decisions and Trial Results Coming in the Next 2 Months

24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in…

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Major Pharma Continues to See Significant Drop in Short Interest

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Short Sellers Run for Cover From Major Biotechs

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

More Content

Are Travel Points Credit Cards a Smart Strategy or a Deception?

Marc Guberti • May 6, 2026

Are Travel Points Credit Cards a Smart Strategy or a Deception?

Joint Bank Accounts Are Dying: Why Just 77% of Married Couples Share Money Now

Carl Sullivan • May 6, 2026

Joint Bank Accounts Are Dying: Why Just 77% of Married Couples Share Money Now

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

Austin Smith • May 6, 2026

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

1 … 194 195 196 197 198 … 392

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Are Travel Points Credit Cards a Smart Strategy or a Deception?

Marc Guberti | 20 minutes ago

Are Travel Points Credit Cards a Smart Strategy or a Deception?

Joint Bank Accounts Are Dying: Why Just 77% of Married Couples Share Money Now

Carl Sullivan | 33 minutes ago

Joint Bank Accounts Are Dying: Why Just 77% of Married Couples Share Money Now

Home
About Us
Contact Us
Financial Tools
Disclaimer and Terms of Use
Privacy Policy
CCPA Privacy Policy
Advertise

© 2026 24/7 Wall St.